Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment.
Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment.
复制标题
DOI:
10.1111/jmwh.13283
复制
发表时间:
2021-11
期刊:
影响因子:
--
通讯作者:
Novick AM
中科院分区:
文献类型:
--
作者:
Pettigrew JA;Novick AM
Nearly half of women in the United States report problems with sexual function. Many healthcare providers do not ask about sexual concerns during routine clinical encounters because of personal discomfort, lack of familiarity with treatment, or the belief that they lack adequate time to address this complex issue. This may be especially true for hypoactive sexual desire disorder (HSDD), the most commonly identified sexual problem among women. HSDD is characterized by a deficiency of sexual thoughts, feelings or receptiveness to sexual stimulation that has been present for at least 6 months, causes personal distress, and is not due to another medical condition. This is an up-to-date overview of HSDD for clinicians, discussing its physiology, assessment, diagnosis, and treatment strategies. While a definitive physiology of HSDD is still unknown, multiple hormones and neurotransmitters likely participate in a Dual-Control Model to balance excitation and inhibition of sexual desire. For assessment and diagnosis, validated screening tools are discussed, and the importance of a biopsychosocial assessment is emphasized, with guidance on how this can be implemented in clinical encounters. The two recently approved medications for HSDD, flibanserin and bremelanotide, are reviewed as well as off-label treatments. Overall, HSDD represents a common yet likely underrecognized disorder that midwives and other healthcare providers who care for women across the lifespan are in a unique position to address. An up-to-date overview on the evaluation and management of Hypoactive Sexual Desire Disorder.
登录
查看更多内容
影响因子:
5.8
作者:
Davis, Susan R.;Baber, Rodney;Wierman, Margaret E.
通讯作者:
Wierman, Margaret E.
DOI:
10.3390/pharmacy9020071
发表时间:
2021-03-27
期刊:
Pharmacy (Basel, Switzerland)
影响因子:
--
作者:
Cieri-Hutcherson NE;Jaenecke A;Bahia A;Lucas D;Oluloro A;Stimmel L;Hutcherson TC
通讯作者:
Hutcherson TC
影响因子:
4.9
作者:
DAVIS, SR;MCCLOUD, P;BURGER, H
通讯作者:
BURGER, H
影响因子:
8.9
作者:
Goldstein, Irwin;Kim, Noel N.;Worsley, Roisin
通讯作者:
Worsley, Roisin
影响因子:
2.5
作者:
Ferguson, DM;Steidle, CP;Crosby, MG
通讯作者:
Crosby, MG